Search by Drug Name or NDC

    NDC 59212-0562-10 Plaquenil 200 mg/1 Details

    Plaquenil 200 mg/1

    Plaquenil is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is HYDROXYCHLOROQUINE SULFATE.

    Product Information

    NDC 59212-0562
    Product ID 59212-562_3daeac21-611e-4b97-82bb-82ab25ce3db4
    Associated GPIs 13000020100305
    GCN Sequence Number 009580
    GCN Sequence Number Description hydroxychloroquine sulfate TABLET 200 MG ORAL
    HIC3 W4A
    HIC3 Description ANTIMALARIAL DRUGS
    GCN 42940
    HICL Sequence Number 004151
    HICL Sequence Number Description HYDROXYCHLOROQUINE SULFATE
    Brand/Generic Brand
    Proprietary Name Plaquenil
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hydroxychloroquine Sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name HYDROXYCHLOROQUINE SULFATE
    Labeler Name Concordia Pharmaceuticals Inc.
    Pharmaceutical Class Antimalarial [EPC], Antirheumatic Agent [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA009768
    Listing Certified Through 2024-12-31

    Package

    NDC 59212-0562-10 (59212056210)

    NDC Package Code 59212-562-10
    Billing NDC 59212056210
    Package 100 TABLET in 1 BOTTLE (59212-562-10)
    Marketing Start Date 2013-06-28
    NDC Exclude Flag N
    Pricing Information N/A